1 Min Read
Feb 15 (Reuters) - Spring Bank Pharmaceuticals Inc :
* Spring Bank Pharmaceuticals provides corporate update and reports 2016 financial and operational results
* Q4 loss per share $0.28 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.